Picture of SyntheticMR AB (publ) logo

SYNT SyntheticMR AB (publ) Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Momentum

Relative Strength (%)
1m-18.22%
3m-14.33%
6m-41.49%
1yr-54.39%
Volume Change (%)
10d/3m+3.03%
Price vs... (%)
52w High-62.57%
50d MA-19.23%
200d MA-34.66%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)45.69
PEG Ratio (f)0.79
EPS Growth (f)138.16%
Dividend Yield (f)0.6%
Valuation (ttm)IndustryMarket
Price to Book Value11.36
Price to Tang. Book13.3
Price to Free Cashflown/a
Price to Sales19.26
EV to EBITDA85.8

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.85%
Return on Equity9.88%
Operating Margin13.49%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSEKm35.6548.345.848.7358.4271.5105.525.18%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+249.22+75.25-74.55-82.24+1092.92+43.21+162.5n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of SyntheticMR AB (publ) EPS forecast chart

Profile Summary

SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
January 1st, 1970
Public Since
October 18th, 2013
No. of Employees
26
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconAktieTorget Stock Exchange
Shares in Issue
41,650,780

SYNT Share Price Performance

Upcoming Events for SYNT

Similar to SYNT

Picture of Alteco Medical AB logo

Alteco Medical AB

se flag iconAktieTorget Stock Exchange

Picture of Audientes A/S logo

Audientes A/S

se flag iconAktieTorget Stock Exchange

Picture of BibbInstruments AB logo

BibbInstruments AB

se flag iconAktieTorget Stock Exchange

Picture of BrainCool AB (publ) logo

BrainCool AB (publ)

se flag iconAktieTorget Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email